发明名称 | CD40-L Inhibitory Peptides | ||
摘要 | The present invention provides compositions comprising peptidyl inhibitors of CD40L-dependent signalling that are not derived from a natural binding partner of CD40L such as CD40, or from a native CD40-CD40L interface. More particularly, the peptidyl inhibitors of the present invention are derived from natural sources that do not express CD40-CD40L costimulatory pathways. The invention also provides synthetic derivatives and analogs of the peptidyl inhibitors having enhanced binding affinity for CD40L or enhanced inhibitory activity relative to their parent molecules. | ||
申请公布号 | US8802634(B2) | 申请公布日期 | 2014.08.12 |
申请号 | US200913003726 | 申请日期 | 2009.07.13 |
申请人 | Phylogica Limited | 发明人 | Watt Paul Michael;Hopkins Richard;Hoffman Katrin |
分类号 | A61K38/16;A61K38/10;A61K38/00;A61K39/385 | 主分类号 | A61K38/16 |
代理机构 | Cooper & Dunham LLP | 代理人 | White John P.;Cooper & Dunham LLP |
主权项 | 1. A composition comprising one or more peptides wherein the peptide comprises a sequence of amino acids other than the sequence of CD40, binds to CD40 ligand (CD40L), partially or completely inhibits interaction of CD40 with CD40L and one or more CD40-CD40L costimulatory effects and comprises a sequence selected from the group consisting of: (i) a sequence set forth in any one of SEQ ID NOs: 1, 2, 5, 7, 19, 20, 23, 25, 35, 36, 39, 41 and 42; (ii) a sequence of a peptidyl fusion comprising a plurality of sequences at (i); and (iii) a sequence of (i) additionally comprising a protein transduction domain. | ||
地址 | Subiaco AU |